Cargando…

The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models

Lung cancer is the leading cause of cancer-related deaths worldwide; hence novel treatments for this malignancy are eagerly needed. Since natural-based compounds represent a rich source of novel chemical entities in drug discovery, we have focused our attention on tambjamines, natural compounds isol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez-García, David, Pérez-Hernández, Marta, Korrodi-Gregório, Luís, Quesada, Roberto, Ramos, Ricard, Baixeras, Núria, Pérez-Tomás, Ricardo, Soto-Cerrato, Vanessa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724027/ https://www.ncbi.nlm.nih.gov/pubmed/31412593 http://dx.doi.org/10.3390/biom9080361

Ejemplares similares

From Proteomic Analysis to Potential Therapeutic Targets: Functional Profile of Two Lung Cancer Cell Lines, A549 and SW900, Widely Studied in Pre-Clinical Research
por: Korrodi-Gregório, Luís, et al.
Publicado: (2016)

Indole-based perenosins as highly potent HCl transporters and potential anti-cancer agents
por: Jowett, Laura A., et al.
Publicado: (2017)

Targeting Autophagy for Cancer Treatment and Tumor Chemosensitization
por: Pérez-Hernández, Marta, et al.
Publicado: (2019)

A Novel Late-Stage Autophagy Inhibitor That Efficiently Targets Lysosomes Inducing Potent Cytotoxic and Sensitizing Effects in Lung Cancer
por: Molero-Valenzuela, Adrià, et al.
Publicado: (2022)

Molecular Interactions of Prodiginines with the BH3 Domain of Anti-Apoptotic Bcl-2 Family Members
por: Hosseini, Ali, et al.
Publicado: (2013)

Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma
por: Locke, Frederick L, et al.
Publicado: (2015)

Lycorine Displays Potent Antitumor Efficacy in Colon Carcinoma by Targeting STAT3
por: Wu, Song, et al.
Publicado: (2018)

Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis
por: Aftabizadeh, Maryam, et al.
Publicado: (2021)

Synthesis and biological evaluation of celastrol derivatives as potent antitumor agents with STAT3 inhibition
por: Xu, Shaohua, et al.
Publicado: (2021)

Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma
por: Espona-Fiedler, Margarita, et al.
Publicado: (2022)

Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds
por: Vishwakarma, Vikalp, et al.
Publicado: (2018)

Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma
por: Pan, Yunbao, et al.
Publicado: (2013)

Small molecule anion carriers facilitate lactate transport in model liposomes and cells
por: Alonso-Carrillo, Daniel, et al.
Publicado: (2023)

KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models
por: Gravina, Giovanni Luca, et al.
Publicado: (2015)

Damnacanthal, a noni anthraquinone, inhibits c-Met and is a potent antitumor compound against Hep G2 human hepatocellular carcinoma cells
por: García-Vilas, Javier A., et al.
Publicado: (2015)

Novel potent azetidine-based compounds irreversibly inhibit Stat3 activation and induce antitumor response against human breast tumor growth in vivo
por: Yue, Peibin, et al.
Publicado: (2022)

Correction: Stat3 inhibitor stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma
por: Pan, Yunbao, et al.
Publicado: (2020)

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway
por: Lee, Jen-Chieh, et al.
Publicado: (2022)

STAT3 Suppresses Cardiomyocytes Apoptosis in CVB3-Induced Myocarditis Via Survivin
por: Wang, Qiaoyu, et al.
Publicado: (2021)

Small molecule anionophores promote transmembrane anion permeation matching CFTR activity
por: Hernando, Elsa, et al.
Publicado: (2018)

RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo
por: Hendruschk, Sandy, et al.
Publicado: (2011)

Downregulation of survivin expression exerts antitumoral effects on mouse breast cancer cells in vitro and in vivo
por: MA, WEN-HUI, et al.
Publicado: (2016)

Erratum to: KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models
por: Gravina, Giovanni Luca, et al.
Publicado: (2016)

Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity
por: Kamerkar, Sushrut, et al.
Publicado: (2022)

Potent antitumor property of Allium bakhtiaricum extracts
por: Vafaee, Kosar, et al.
Publicado: (2019)

Furan-Conjugated Tripeptides as Potent Antitumor Drugs
por: Ali, Hunain, et al.
Publicado: (2020)

In vivo antitumor activity of liposome-plasmid DNA encoding mutant survivin-T34A in cervical cancer
por: Qiu, Fang, et al.
Publicado: (2018)

SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties
por: Warren, Michael C., et al.
Publicado: (2023)

Design, Synthesis and Structure-Activity Relationship Studies of Novel Survivin Inhibitors with Potent Anti-Proliferative Properties
por: Xiao, Min, et al.
Publicado: (2015)

The natural compound gracillin exerts potent antitumor activity by targeting mitochondrial complex II
por: Min, Hye-Young, et al.
Publicado: (2019)

Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer
por: Ryan, B, et al.
Publicado: (2005)

AATF is Overexpressed in Human Head and Neck Squamous Cell Carcinoma and Regulates STAT3/Survivin Signaling
por: Fu, Lin, et al.
Publicado: (2021)

Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity
por: Chiang, Chen-Yi, et al.
Publicado: (2018)

Evaluation of antitumor activity of survivin short interfering RNA delivered by lipid nanoparticles in colon cancer in vitro and in vivo
por: Wang, Tianyou, et al.
Publicado: (2017)

Shikonin Derivatives from Onsoma visianii Decrease Expression of Phosphorylated STAT3 in Leukemia Cells and Exert Antitumor Activity
por: Todorovic, Zeljko, et al.
Publicado: (2021)

Discovery of Novel Quinazoline Derivatives as Potent Antitumor Agents
por: Niu, Zhenxi, et al.
Publicado: (2022)

A survivin-responsive, conditionally replicating adenovirus induces potent cytocidal effects in adult T-cell leukemia/lymphoma
por: Suzuki, Shinsuke, et al.
Publicado: (2019)

A Novel Monoclonal Antibody Targeting Cancer-Specific Plectin Has Potent Antitumor Activity in Ovarian Cancer
por: Perez, Samantha M., et al.
Publicado: (2021)

STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers
por: Kim, Jae-Sung, et al.
Publicado: (2016)

The survivin-ran inhibitor LLP-3 decreases oxidative phosphorylation, glycolysis and growth of neuroblastoma cells
por: Galiger, Celimene, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_68jd089v1ljt23lifrunfv1hqn